$24.76
2.90% day before yesterday
Nasdaq, May 30, 10:02 pm CET
ISIN
US98419J2069
Symbol
XOMA
Sector
Industry

XOMA Corporation Stock price

$24.76
+0.72 3.00% 1M
-7.67 23.65% 6M
-1.52 5.78% YTD
-0.48 1.90% 1Y
+5.75 30.25% 3Y
+4.68 23.31% 5Y
-45.24 64.63% 10Y
Nasdaq, Closing price Fri, May 30 2025
-0.74 2.90%
ISIN
US98419J2069
Symbol
XOMA
Sector
Industry

Key metrics

Market capitalization $296.30m
Enterprise Value $317.28m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 7.15
P/S ratio (TTM) P/S ratio 6.67
P/B ratio (TTM) P/B ratio 3.50
Revenue growth (TTM) Revenue growth 664.20%
Revenue (TTM) Revenue $44.40m
EBIT (operating result TTM) EBIT $-14.73m
Free Cash Flow (TTM) Free Cash Flow $-26.78m
Cash position $92.65m
EPS (TTM) EPS $-1.04
P/E forward negative
P/S forward 6.41
EV/Sales forward 6.87
Short interest 1.99%
Show more

Is XOMA Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,782 stocks worldwide.

XOMA Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

4 Analysts have issued a XOMA Corporation forecast:

3x Buy
75%
1x Hold
25%

Analyst Opinions

4 Analysts have issued a XOMA Corporation forecast:

Buy
75%
Hold
25%

Financial data from XOMA Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
44 44
664% 664%
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 39 39
40% 40%
88%
- Research and Development Expense 4.17 4.17
3,108% 3,108%
9%
-14 -14
37% 37%
-31%
- Depreciation and Amortization 0.75 0.75
14% 14%
2%
EBIT (Operating Income) EBIT -15 -15
36% 36%
-33%
Net Profit -19 -19
56% 56%
-42%

In millions USD.

Don't miss a Thing! We will send you all news about XOMA Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

XOMA Corporation Stock News

Neutral
GlobeNewsWire
5 days ago
EMERYVILLE, Calif. and LUND, Sweden, May 27, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ: XOMA), the biotech royalty aggregator, and BioInvent International AB (“BioInvent”) (Nasdaq Stockholm: BINV), a biotech company focused on the discovery and development of novel and first-in-class immune-modulatory antibodies for cancer immunotherapy, today announced XOMA Royalty has purchase...
Neutral
GlobeNewsWire
25 days ago
EMERYVILLE, Calif., May 07, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ: XOMA), the biotech royalty aggregator, announced today its Chief Executive Officer, Owen Hughes, and Chief Investment Officer, Brad Sitko, will be featured speakers at the H.C. Wainwright 1st Annual Royalty Company Virtual Conference being held May 13, 2025.
Neutral
GlobeNewsWire
about 2 months ago
XOMA Royalty sold the remaining Kinnate pipeline assets for a total of up to $270 million in upfront and milestone payments, plus royalties on commercial sales at rates ranging from low single digits to mid-teens
More XOMA Corporation News

Company Profile

XOMA Corp. engages in the discovery and development of therapeutics derived from platform of antibody technologies. Its products includes X358, X213, X129, and gevokizumab. The company was founded by Patrick J. Scannon in 1981 and is headquartered in Emeryville, CA.

Head office United States
CEO Owen Hughes
Employees 13
Founded 1981
Website www.xoma.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today